Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sativex for Detrusor Overactivity in MS
NCT00678795Phase 3Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Aug 2002
- Primary completion
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cannabidiol in detrusor overactivity, sponsored by Jazz Pharmaceuticals plc. Started Aug 2002; status: completed.
02
Drugs
cannabidiol
03
Conditions
detrusor overactivity
Beyond the preview
Go deeper on NCT00678795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00678795.